Phase and cell cycle specificity of pyrazofurin action.
D000577:Amides; D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects*; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D007042:Hypoxanthines / Q000494:pharmacology; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy / Q000473:pathology*; D009696:Nucleic Acids / Q000378:metabolism; D009964:Orotidine-5'-Phosphate Decarboxylase / Q000378:metabolism; D011720:Pyrazoles; D011741:Pyrimidine Nucleosides / Q000378:metabolism; D012263:Ribonucleosides / Q000494:pharmacology*; D012266:Ribose; D014498:Uracil / Q000378:metabolism
D000577:Amides; D000964:Antimetabolites, Antineoplastic; D007042:Hypoxanthines; D009696:Nucleic Acids; D011720:Pyrazoles; D011741:Pyrimidine Nucleosides; D012263:Ribonucleosides; C002997:pyrazofurin; D014498:Uracil; D012266:Ribose; D009964:Orotidine-5'-Phosphate Decarboxylase